Tag: pharmaceuticals
-
Biotech Begins Clinical Trial for Stroke Treatment
ZZ Biotech, a biotechnology company in Houston, began a clinical trial of an experimental drug to treat acute ischemic stroke, where blood flow to the brain is blocked by a clot. The drug being tested is 3K3A-APC, the result of research first conducted at University of Southern California and Scripps Research Institute in California, and…
-
Targeted Cancer Therapies Result in Fewer Side Effects
An analysis of data from early-phase clinical trials indicates patients treated with targeted cancer therapies have a lower risk of more serious side effects than with traditional chemotherapy. The findings from researchers at the Institute of Cancer Research in London, U.K., and Royal Marsden NHS Foundation Trust appear in this month’s issue of the journal…
-
Foundation Medicine, Clovis Oncology Partner on Diagnostics
Genomic diagnostics provider Foundation Medicine in Cambridge, Massachusetts and biotechnology company Clovis Oncology in Boulder, Colorado, will collaborate on diagnostics to identify cancer patients most likely to respond to rucaparib, a drug candidate in development by Clovis Oncology. Rucaparib is a small-molecule drug developed to treat tumors with defective BRCA gene function in breast and…
-
Novartis, Penn to Partner on Cancer Immunotherapies
The global pharmaceutical company Novartis and University of Pennsylvania in Philadelphia will collaborate on a new type of immunotherapy to treat leukemia and other cancers. Novartis and Penn will also form the Center for Advanced Cellular Therapies on the Penn campus to conduct research on related immunotherapies. The partnership will conduct research, develop and take…
-
Clinical Trial Tests Skin Cell Spray as Leg Ulcer Therapy
A clinical trial by researchers at Healthpoint Biotherapeutics in Fort Worth, Texas found a spray-on skin cell therapy to be faster and more effective in healing venous leg ulcers than the standard care. The findings, with contributions from research colleagues at University of Miami, University of North Carolina, and Barry University, appear online in the…
-
Special: Health Care Experts Propose Sweeping Cost Control Changes
Updated: 4 August 2012 A group of noted health care policy experts offer a series of proposals they say can rein in health care costs, with implications for the federal budget, the economy as a whole, and developers of pharmaceuticals and medical devices. The panel, convened by the Center for American Progress, a progressive think-tank…
-
Biopharm Gains SBIR Grant for Cystic Fibrosis Treatment
OrPro Therapeutics Inc., a biopharmaceutical company in San Diego, received a Small Business Innovation Research (SBIR) grant from National Institutes of Health, to advance development of its lead product, ORP-100, for the treatment of cystic fibrosis. The company did not disclose the amount of the award from the National Heart, Lung and Blood Institute of…
-
European Venture Volume Up, Science Company Investments Drop
Venture capital (VC) investment volume rose in the second quarter of 2012 compared to the second quarter of 2011, but the number of VC deals dropped sharply. The number and volume of investments in European science-based companies, says financial industry research service Dow Jones VentureSource, declined by double-digit percentages in the second quarter of 2012…
-
Company, University Share Stem Cell Research Funds
Researchers at StemCells Inc. in Newark, California and University of California in Irvine will share a $20 million award from the California Institute for Regenerative Medicine (CIRM) to conduct research on stem cells leading to clinical trials to treat cervical spinal cord injury. The grant was one of several awards announced last week by CIRM,…
-
Computer Simulation Models Effects of HIV Policies
A Brown University epidemiologist developed a computer simulation that can model the spread of HIV in New York City, under various scenarios of interventions. Brandon Marshall (pictured left) discusses his work in two sessions at this week’s International AIDS Society Conference in Washington, D.C. The model creates a community of individual actors, who engage in…